VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO)

NASDAQ: CFO · Real-Time Price · USD
71.92
+0.11 (0.15%)
Jul 14, 2025, 3:22 PM - Market open
0.15%
Assets $415.68M
Expense Ratio 0.37%
PE Ratio 20.92
Shares Out 5.85M
Dividend (ttm) $0.95
Dividend Yield 1.32%
Ex-Dividend Date Jul 10, 2025
Payout Frequency Monthly
Payout Ratio 27.67%
Volume 2,089
Open 71.68
Previous Close 71.81
Day's Range 71.68 - 71.99
52-Week Low 60.03
52-Week High 74.07
Beta 0.72
Holdings 505
Inception Date Jul 2, 2014

About CFO

Fund Home Page

The VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of the largest US stocks by market cap, screened for positive earnings and weighted by volatility. The fund can move to 75% cash maximum in market downturns. CFO was launched on Jul 2, 2014 and is issued by VictoryShares.

Asset Class Equity
Category Large Blend
Region North America
Stock Exchange NASDAQ
Ticker Symbol CFO
ETF Provider VictoryShares
Index Tracked Nasdaq Victory U.S. Large Cap 500 Long/Cash Volatility Weighted Index

Top 10 Holdings

3.38% of assets
Name Symbol Weight
Evergy, Inc. EVRG 0.38%
Linde plc LIN 0.36%
CME Group Inc. CME 0.35%
Atmos Energy Corporation ATO 0.34%
Automatic Data Processing, Inc. ADP 0.33%
Cencora, Inc. COR 0.33%
Marsh & McLennan Companies, Inc. MMC 0.33%
Intercontinental Exchange, Inc. ICE 0.32%
The Coca-Cola Company KO 0.32%
VeriSign, Inc. VRSN 0.32%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Jul 10, 2025 $0.08563 Jul 11, 2025
Jun 9, 2025 $0.11262 Jun 10, 2025
May 8, 2025 $0.03005 May 9, 2025
Apr 10, 2025 $0.09739 Apr 11, 2025
Mar 10, 2025 $0.100 Mar 11, 2025
Feb 7, 2025 $0.0455 Feb 10, 2025
Full Dividend History

Performance

CFO had a total return of 10.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.37%.

News

Kashiv Biosciences Expands Leadership Team with New Chief Financial Officer and Chief Legal Officer

PISCATAWAY, N.J.--(BUSINESS WIRE)--Kashiv BioSciences, LLC, a global vertically integrated biopharmaceutical company, announced the appointment of Mandar Borkar as Global Chief Financial Officer (CFO)...

7 months ago - Business Wire

CFO: A Timing Methodology Failing For 10 Years

VictoryShares US 500 Enhanced Volatility Wtd ETF (CFO) combines low-volatility weighting with market timing. CFO's unconventional timing rules have reduced drawdown and volatility but result in lower ...

8 months ago - Seeking Alpha